Topical roflumilast 0.3% cream for mild hidradenitis suppurativa: A prospective case series

Authors

• Nagasai C. Adusumilli, Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
• Nikkia Zarabian, Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
• Mina Farah, Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
• Emily C. Murphy, Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
• Adam J. Friedman, Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.

Document Type

Journal Article

Publication Date

3-1-2026

Journal

JAAD case reports

Volume

69

DOI

10.1016/j.jdcr.2025.12.016

Keywords

hidradenitis suppurativa; immunodermatology; immunomodulation; medical dermatology; pruritus; roflumilast

APA Citation

Adusumilli, Nagasai C.; Zarabian, Nikkia; Farah, Mina; Murphy, Emily C.; and Friedman, Adam J., "Topical roflumilast 0.3% cream for mild hidradenitis suppurativa: A prospective case series" (2026). GW Authored Works. Paper 8974.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8974

Department

Dermatology